Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Pharmaceutical regulations in Iraq: from medicine approval to postmarketing
Ali Azeez Al-Jumaili1, Manal Mohammed Younus2, Yasmine J A Kannan3
1University of Baghdad College of Pharmacy, Baghdad, Iraq.
Background:
Recent information on regulation of the pharmaceutical sector in Iraq is scarce.
Aims:
This report summarizes the regulations governing pharmaceutical products in Iraq, assesses the challenges faced and makes recommendations to tackle these issues.
Methods:
The Iraq pharmaceutical country profile 2020, prepared by the Iraqi Ministry of Health in collaboration with the World Health Organization (WHO) in 2020, was the main source of information.
Results:
Despite all the efforts by the Ministry of Health to provide adequate and safe medicines, the Iraqi pharmaceutical sector has several challenges, including inadequate budget allocated to the ministry, shortages in essential medicines, underutilization of electronic technologies in the management of regulation-related work, a large number of substandard and falsified medications in the private sector and a stagnant national pharmaceutical industry.
Conclusion:
The Ministry of Health needs more financial support from the federal government to fund its activities and technical support from international health organizations to provide training and resources.
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Clinically Relevant Drug Product Specifications: Methods of Establishment

